Free tool
Dividend paying stocks
We cover 32 companies that currently pay a dividend. The median market value in the group is $2.08B. Across the group, the median move over the past trading day is +0.73%. 71% of the 31 with a 200-day average trade above it. Price change over the past year runs from −22.0% to +30.2% across the middle 80 percent of the group, with a median of −0.0%.
Other lists in this group
Table
32 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% | Oct 13, 2026 |
| NOT.DE | Novartis AG | $300.14B | Mega cap | +28.89% | Oct 27, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% | Oct 21, 2026 |
| ABL.DE | Abbott Laboratories | $200.44B | Mega cap | −10.02% | Oct 14, 2026 |
| DAP.DE | Danaher Corporation | $151.59B | Large cap | +6.90% | Oct 20, 2026 |
| 2M6.DE | Medtronic plc | $117.57B | Large cap | +2.65% | Sep 1, 2026 |
| A58.DE | Elevance Health, Inc. | $87.59B | Large cap | −19.30% | Oct 21, 2026 |
| DIM.PA | Sartorius Stedim Biotech S.A. | $21.78B | Large cap | +11.64% | Oct 22, 2026 |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $21.77B | Large cap | +11.32% | Oct 22, 2026 |
| SRT.DE | Sartorius Aktiengesellschaft | $15.54B | Large cap | +21.79% | Oct 22, 2026 |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% | Oct 21, 2026 |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% | Sep 4, 2026 |
| VIRP.PA | Virbac SA | $3.24B | Mid cap | −2.08% | Sep 17, 2026 |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% | Oct 21, 2026 |
| GNS.L | Genus plc | $2.08B | Mid cap | −12.94% | Sep 10, 2026 |
| DIA.WA | Diagnostyka S.A. | $1.54B | Small cap | −17.76% | Sep 10, 2026 |
| VITR.ST | Vitrolife AB (publ) | $1.35B | Small cap | −30.23% | Oct 22, 2026 |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% | Sep 10, 2026 |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% | Sep 9, 2026 |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +13.96% | Oct 22, 2026 |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% | Sep 24, 2026 |
| TTALO.HE | Terveystalo Oyj | $1.14B | Small cap | −22.31% | Oct 21, 2026 |
| VETO.PA | Vetoquinol SA | $973.12M | Small cap | −6.37% | Sep 11, 2026 |
| DYVOX.ST | Dynavox Group AB (publ) | $850.75M | Small cap | −39.29% | Oct 21, 2026 |
| ARJO-B.ST | Arjo AB (publ) | $802.95M | Small cap | −15.25% | Oct 22, 2026 |
| MEDI.OL | Medistim ASA | $512.66M | Small cap | +4.43% | Oct 23, 2026 |
| REG1V.HE | Revenio Group Oyj | $494.52M | Small cap | −38.54% | Sep 8, 2026 |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% | Sep 29, 2026 |
| HUM.ST | Humana AB (publ) | $350.23M | Small cap | +81.84% | Oct 22, 2026 |
| BION.SW | BB Biotech AG | — | — | +84.12% | Oct 23, 2026 |
| MOVE.SW | Medacta Group SA | — | — | −10.60% | Sep 9, 2026 |
| NOVN.SW | Novartis AG | — | — | +30.24% | Oct 27, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.